Orix (IX) Gains from Sales and Divestitures (2011 - 2026)

Orix has reported Gains from Sales and Divestitures for 15 years, with the latest figure at -$447.1 million in Q1 2026.

• For the quarter ending Q1 2026, Gains from Sales and Divestitures rose 10.99% year-over-year to -$447.1 million; the trailing twelve-month figure through Mar 2026 stood at -$447.1 million (up 10.99% YoY), and the FY2026 full-year result was -$465.8 million, up 7.27% from the prior year.
• Gains from Sales and Divestitures for Q1 2026 stood at -$447.1 million, down from -$210.4 million in the prior quarter.
• The five-year high for Gains from Sales and Divestitures was -$64.1 million in Q2 2023, with the low at -$502.3 million in Q1 2025.
• Average Gains from Sales and Divestitures over 5 years is -$289.4 million, with a median of -$277.1 million recorded in 2022.
• Year-over-year, Gains from Sales and Divestitures soared 57.44% in 2023 and slumped 55.53% in 2024.
• Tracing IX's Gains from Sales and Divestitures over 5 years: stood at -$277.1 million in 2022, then rose by 8.48% to -$253.6 million in 2023, then slipped by 18.0% to -$299.3 million in 2024, then increased by 29.7% to -$210.4 million in 2025, then slumped by 112.47% to -$447.1 million in 2026.
• The last three Gains from Sales and Divestitures figures came in at -$447.1 million (Q1 2026), -$210.4 million (Q3 2025), and -$502.3 million (Q1 2025), per Business Quant data.

Peer Comparison